What are Parathyroid hormone analog drugs?

Parathyroid hormone analog drugs are pharmacologic agents that share a common mechanism (typically targeting PTH1 receptor). 4 are currently marketed, with 1 more in clinical development.

What are the marketed Parathyroid hormone analog drugs?

Marketed Parathyroid hormone analog drugs include FORSTEO, Teriparatide Pen Injector, Teriparatide (Forteo), Teriparatide (rDNA origin).

Parathyroid hormone analog

4 marketed 1 in Phase 3

This page covers all Parathyroid hormone analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PTH1 receptor, PTH1 receptor (parathyroid hormone 1 receptor), PTH1 receptor (PTHR1).

Targets

PTH1 receptor · PTH1 receptor (parathyroid hormone 1 receptor) · PTH1 receptor (PTHR1) · PTH1R

Marketed (4)

FORSTEO · Shenzhen Salubris Pharmaceuticals Co., Ltd. · Endocrinology / Bone Metabolism
Forsteo (teriparatide) is a recombinant human parathyroid hormone analog that stimulates bone formation by activating PTH1 receptors on osteoblasts.
Teriparatide Pen Injector · University of Edinburgh · Endocrinology / Bone Metabolism
Teriparatide is a recombinant parathyroid hormone analog that stimulates osteoblasts to increase bone formation and remodeling.
Teriparatide (Forteo) · M.D. Anderson Cancer Center · Endocrinology / Bone Metabolism
Teriparatide is a recombinant parathyroid hormone analog that stimulates osteoblasts to increase bone formation and remodeling.
Teriparatide (rDNA origin) · Bio Sidus SA · Endocrinology / Bone Metabolism
Teriparatide is a recombinant human parathyroid hormone (PTH 1-34) that stimulates osteoblasts to increase bone formation and remodeling.

Phase 3 pipeline (1)

Teriparatide (PF708) · Pfenex, Inc · Endocrinology
Teriparatide is a recombinant form of parathyroid hormone used to treat osteoporosis by stimulating bone growth.